Laman UtamaAGIO • BMV
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
$983.02
Julat tahun
$397.93 - $983.02
Permodalan pasaran
3.18B USD
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 8.96J | 21.15% |
Perbelanjaan pengendalian | 38.54J | 49.24% |
Pendapatan bersih | 947.92J | 1,137.97% |
Margin untung bersih | 10.57K | 956.76% |
Pendapatan bagi setiap syer | -1.47 | 10.66% |
EBITDA | -101.47J | -2.21% |
Kadar cukai berkesan | 5.31% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.00B | 55.18% |
Jumlah aset | 1.79B | 77.89% |
Jumlah liabiliti | 165.12J | 37.13% |
Jumlah ekuiti | 1.63B | — |
Syer tertunggak | 57.03J | — |
Harga kepada buku | 34.46 | — |
Pulangan pada aset | -20.04% | — |
Pulangan pada modal | -21.31% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 947.92J | 1,137.97% |
Tunai daripada operasi | -84.22J | -36.62% |
Tunai daripada pelaburan | 250.79J | 537.49% |
Tunai daripada pembiayaan | 2.64J | 40.12% |
Perubahan bersih dalam tunai | 169.21J | 928.66% |
Aliran tunai bebas | -3.03J | 95.64% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
385
